MedPath

In-vivo Efficacy Study of Patient Pre-operative Preps

Phase 3
Completed
Conditions
Bacterial Reduction on Skin Flora Post-product Application
Interventions
Drug: Normal saline
Drug: 3M CHG/IPA Prep Tint 10.5-mL
Drug: 3M CHG/IPA Prep Tint 26-mL
Registration Number
NCT01968707
Lead Sponsor
Solventum US LLC
Brief Summary

The purpose of this study is to determine the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Detailed Description

The primary efficacy is evaluated by demonstration that the product provides a lower bound of the 95% confidence interval of percent responders that is greater than or equal to 70%.

On the abdominal sites, a responder is defined as a subject with a 2-log10 per cm2 bacterial reduction at 10 minutes and for whom the skin flora does not return to baseline at 6 hours.

On the inguinal sites, a responder is defined as a subject with a 3-log10 per cm2 bacterial reduction at 10 minutes and for whom the skin flora does not return to baseline at 6 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
426
Inclusion Criteria
  • Subjects of any race
  • Subjects in good general health
  • Minimum skin flora baseline requirements on abdomen and groin
Exclusion Criteria
  • Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test areas
  • Topical antimicrobial exposure within 14 days prior to screening and treatment days
  • Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Normal SalineNormal salineApply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.
3M CHG/IPA Prep Tint 10.5 mL3M CHG/IPA Prep Tint 10.5-mLApply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.
3M CHG/IPA Prep Tint 26-mL3M CHG/IPA Prep Tint 26-mLApply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.
ChloraPrep Hi-Lite OrangeChloraPrep Hi-Lite OrangeApply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.
Primary Outcome Measures
NameTimeMethod
Responder Ratebaseline, 10 minutes post-product application and 6 hour post-product application

On the abdominal region a responder was a subject with a 2 log10/cm2 bacterial reduction at 10 minutes and for whom the skin flora did not return to baseline.

On the inguinal region a responder was a subject with a 3 log10/cm2 bacterial reduction at 10 minutes and for whom the skin flora did not return to baseline.

Secondary Outcome Measures
NameTimeMethod
Reduction of Skin Flora 10 Minutes Post-treatment10 minutes

log10/cm2 reduction of skin flora, relative to treatment day baseline (log10/cm2), at 10 minutes post-treatment

Safety as Assessed by Skin Irritation (Dryness, Edema, Erythema, Rash) Rating ScoreAssessed at baseline (pre-treatment) and 10 minute post-treatment and 6 hour post-treatment.

Skin irritation (dryness, edema, erythema, rash) assessed on the test sites using a 0-3 rating scale: 0=no reaction, 1=mild, 2=moderated, 3=severe

Skin Flora Baseline for the Abdominal and Inguinal Region.Baseline

Log10/cm2 baseline skin flora for abdominal and inguinal regions

Reduction of Skin Flora 6 Hours Post-treatment6 hours

log10/cm2 reduction of skin flora, relative to treatment day baseline (log10/cm2), at 6 hours post-treatment

Skin Flora Recovery 6-hours Post-treatment6 hours post-treatment

Log10/cm2 recovery of skin flora at 6 hours following application of study treatment

Skin Flora Recovery 10 Minutes Post-treatment10 minutes post-treatment

Log10/cm2 recovery of skin flora at 10 minutes following application of study treatments

Trial Locations

Locations (1)

Microbiotest

🇺🇸

Sterling, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath